Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

199 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treatment Satisfaction and Well-Being With Continuous Glucose Monitoring in People With Type 1 Diabetes: An Analysis Based on the GOLD Randomized Trial.
Pylov D, Polonsky W, Imberg H, Holmer H, Hellman J, Wijkman M, Bolinder J, Heisse T, Dahlqvist S, Nyström T, Schwarz E, Hirsch I, Lind M. Pylov D, et al. Among authors: bolinder j. J Diabetes Sci Technol. 2025 Jan;19(1):143-152. doi: 10.1177/19322968231183974. Epub 2023 Jul 27. J Diabetes Sci Technol. 2025. PMID: 37501366 Free PMC article. Clinical Trial.
Intermittently scanned continuous glucose monitoring compared with blood glucose monitoring is associated with lower HbA1c and a reduced risk of hospitalisation for diabetes-related complications in adults with type 2 diabetes on insulin therapies.
Nathanson D, Eeg-Olofsson K, Spelman T, Bülow E, Kyhlstedt M, Levrat-Guillen F, Bolinder J. Nathanson D, et al. Among authors: bolinder j. Diabetologia. 2025 Jan;68(1):41-51. doi: 10.1007/s00125-024-06289-z. Epub 2024 Oct 26. Diabetologia. 2025. PMID: 39460755 Free PMC article.
Discordance between mean glucose and time in range in relation to HbA1c in individuals with type 1 diabetes: results from the GOLD and SILVER trials.
Sterner Isaksson S, Imberg H, Hirsch IB, Schwarcz E, Hellman J, Wijkman M, Bolinder J, Nyström T, Holmer H, Hallström S, Ólafsdóttir AF, Pekkari S, Polonsky W, Lind M. Sterner Isaksson S, et al. Among authors: bolinder j. Diabetologia. 2024 Aug;67(8):1517-1526. doi: 10.1007/s00125-024-06151-2. Epub 2024 Apr 26. Diabetologia. 2024. PMID: 38668761 Free PMC article. Clinical Trial.
Evaluation of Effects of Continuous Glucose Monitoring on Physical Activity Habits and Blood Lipid Levels in Persons With Type 1 Diabetes Managed With Multiple Daily Insulin Injections: An Analysis Based on the GOLD Randomized Trial (GOLD 8).
Nyström T, Schwarz E, Dahlqvist S, Wijkman M, Ekelund M, Holmer H, Bolinder J, Hellman J, Imberg H, Hirsch IB, Lind M. Nyström T, et al. Among authors: bolinder j. J Diabetes Sci Technol. 2024 Jan;18(1):89-98. doi: 10.1177/19322968221101916. Epub 2022 Jun 8. J Diabetes Sci Technol. 2024. PMID: 35677967 Free PMC article. Clinical Trial.
New Insulins, Biosimilars, and Insulin Therapy.
Danne T, Heinemann L, Bolinder J. Danne T, et al. Among authors: bolinder j. Diabetes Technol Ther. 2022 Mar;24(S1):S35-S57. doi: 10.1089/dia.2022.2503. Diabetes Technol Ther. 2022. PMID: 35475698 No abstract available.
New Insulins, Biosimilars, and Insulin Therapy.
Danne T, Heinemann L, Bolinder J. Danne T, et al. Among authors: bolinder j. Diabetes Technol Ther. 2021 Jun;23(S2):S46-S68. doi: 10.1089/dia.2021.2504. Diabetes Technol Ther. 2021. PMID: 34061629 No abstract available.
199 results